These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9404974)

  • 1. The use of antifibrinolytic agents results in a reduction in transfused blood products during liver transplantation.
    Ramsay MA
    Liver Transpl Surg; 1997 Nov; 3(6):665-8. PubMed ID: 9404974
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use of synthetic antifibrinolytic agents during liver transplantation.
    Kang Y
    Semin Thromb Hemost; 1993; 19(3):258-61. PubMed ID: 8362255
    [No Abstract]   [Full Text] [Related]  

  • 3. Coagulation and fibrinolysis in orthotopic liver transplantation: current views and insights.
    Porte RJ
    Semin Thromb Hemost; 1993; 19(3):191-6. PubMed ID: 8362248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolytics do not reduce transfusion requirements in patients undergoing orthotopic liver transplantation.
    Kufner RP
    Liver Transpl Surg; 1997 Nov; 3(6):668-74; discussion 674-6. PubMed ID: 9404975
    [No Abstract]   [Full Text] [Related]  

  • 5. Coagulation and liver transplantation.
    Kang Y
    Transplant Proc; 1993 Apr; 25(2):2001-5. PubMed ID: 8470257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfusion based on clinical coagulation monitoring does reduce hemorrhage during liver transplantation.
    Kang Y
    Liver Transpl Surg; 1997 Nov; 3(6):655-9. PubMed ID: 9404972
    [No Abstract]   [Full Text] [Related]  

  • 7. Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation.
    Kaspar M; Ramsay MA; Nguyen AT; Cogswell M; Hurst G; Ramsay KJ
    Anesth Analg; 1997 Aug; 85(2):281-5. PubMed ID: 9249100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombelastographic evidence of hyperfibrinolysis during liver transplantation for familial amyloidotic polyneuropathy ATTR met 30.
    Viana JS; Pereira MG; Lozano L; Vieira H; Palmeiro A; Lourenço M; Tavares CA; Seco C; Neves S; Bento C; Perdigoto R; Ferrer-Antunes C; Craveiro AL; Furtado L
    Transplant Proc; 2000 Dec; 32(8):2645-6. PubMed ID: 11134740
    [No Abstract]   [Full Text] [Related]  

  • 9. Intraoperative monitoring and postoperative reevaluation of hemostasis in orthotopic liver transplantation.
    Azad SC; Kratzer MA; Groh J; Welte M; Haller M; Pratschke E
    Semin Thromb Hemost; 1993; 19(3):233-7. PubMed ID: 8362253
    [No Abstract]   [Full Text] [Related]  

  • 10. Thromboelastography in liver transplantation.
    Kang Y
    Semin Thromb Hemost; 1995; 21 Suppl 4():34-44. PubMed ID: 8747686
    [No Abstract]   [Full Text] [Related]  

  • 11. Postoperative fibrinolysis diagnosed by thrombelastography.
    Liu G; Bowkett J; Przybylowski G; Bellomo R; McNicol PL
    Anaesth Intensive Care; 2000 Feb; 28(1):77-81. PubMed ID: 10701043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of thromboelastometry in the assessment of hemostasis during orthotopic liver transplantation reduces the demand for blood products.
    Trzebicki J; Flakiewicz E; Kosieradzki M; Blaszczyk B; Kołacz M; Jureczko L; Pacholczyk M; Chmura A; Lagiewska B; Lisik W; Wasiak D; Kosson D; Kwiatkowski A; Lazowski T
    Ann Transplant; 2010; 15(3):19-24. PubMed ID: 20877262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of aprotinin in orthotopic liver transplantation.
    Suárez M; Sangro B; Herrero JI; Picardi A; Páramo JA; Quiroga J; Pardo F; Cienfuegos J; Carrera J; Hidalgo F
    Semin Thromb Hemost; 1993; 19(3):292-6. PubMed ID: 7689754
    [No Abstract]   [Full Text] [Related]  

  • 14. MELD score and blood product requirements during liver transplantation: no link.
    Massicotte L; Beaulieu D; Roy JD; Marleau D; Vandenbroucke F; Dagenais M; Lapointe R; Roy A
    Transplantation; 2009 Jun; 87(11):1689-94. PubMed ID: 19502961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aspects of hemostasis in experimental pulmonary homotransplant].
    Morino F; Olivero S; Traldi A; Bezzi P; Vezzosi E; Ibra F; Romagna I
    Minerva Med; 1968 Jul; 59(59):3267-76. PubMed ID: 4876929
    [No Abstract]   [Full Text] [Related]  

  • 16. Anaphylaxis with associated fibrinolysis, reversed with tranexamic acid and demonstrated by thrombelastography.
    De Souza RL; Short T; Warman GR; Maclennan N; Young Y
    Anaesth Intensive Care; 2004 Aug; 32(4):580-7. PubMed ID: 15675222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of coagulopathy during liver transplantation: experience with the first 75 cases using thrombelastography.
    McNicol PL; Liu G; Harley ID; McCall PR; Przybylowski GM; Bowkett J; Angus PW; Hardy KJ; Jones RM
    Anaesth Intensive Care; 1994 Dec; 22(6):659-65. PubMed ID: 7892968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation, solvent-detergent treated plasma and antifibrinolytics.
    de Jonge J; Groenland TH; Metselaar HJ; IJzermans JN; van Vliet HH; Visser L; Tilanus HW
    Anesth Analg; 2003 Apr; 96(4):1231-1232. PubMed ID: 12651692
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of high-dose aprotinin on hemostasis and blood requirement in orthotopic liver transplantation.
    Grosse H; Lobbes W; Frambach M; Ringe B; Barthels M
    Semin Thromb Hemost; 1993; 19(3):302-5. PubMed ID: 7689757
    [No Abstract]   [Full Text] [Related]  

  • 20. [Blood coagulation and fibrinolysis in venous blood after prophylactic use of antifibrinolytic agents in heart surgery with the use of xtracorporeal circulation].
    Deutschinoff A; Dimitrov D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):166-73. PubMed ID: 4174654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.